Erhalte eine Antwort von diesem Arbeitgeber
Dein Lebenslauf und dein Anschreiben, genau auf das zugeschnitten, was gesucht wird.
iBET is offering a Research Fellowship (MSc) in Translational Immunology within the AdCAM project. The role focuses on hiPSC-derived macrophages, enabling scalable bioprocessing and CAR constructs. Strong emphasis on teamwork, independent work, and clear scientific communication.
The candidate should hold a Master’s in a related field, have experience with hPSC and genetic engineering, and demonstrate proficiency in English. The fellowship lasts 12 months with a March 1, 2026 start date.
iBET,has an open position for a research fellowship in the field of Translational Immunology available within the project “AdCAM – Scalable bioprocessing of engineered hiPSC-derived macrophages with an adaptable CAR“, financed by iBETXplore.
Master’s degree in Biological, Chemical or Biomedical Engineering, Biotechnology, Biology, Biochemistry, Immunology, or related areas, with an average classification of at least 18.
The candidate should have experience in working with human pluripotent stem cells (hPSC) and hPSC genetic engineering.
We value knowledge and experience in the following topics:
The candidate is expected to be motivated, self-driven, and able to work in a team, but also independently.
Good command of the English language, both spoken and written, is required (candidates with internships and/or periods abroad will be valued).
Engineering human induced pluripotent stem cells (hiPSC) to generate a hiPSC-derived macrophage cell line that expresses a CAR construct and establishing the scale‑up production in bioreactors. Main tasks include:
The fellowship will have a duration of 12months, eventually renewed until the end of project, without prejudice of the maximum limits foreseen by law. The expected starting date is 1 of March of 2026.